Trial studying safety and effects for Stroke, Acute
Official title Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
ClinicalTrials.gov ID: NCT06569121
What this study is testing
- What it's testing
- The study aims to find out if a telehealth-delivered group lifestyle program is more effective than waiting for treatment.
- Who it's for
- The study is looking for people who have recently had a stroke.
- What's involved
- Participants will be randomly assigned to either receive the online group lifestyle program or join a waitlist for six months.
- Time commitment
- The study involves a six-month period of either active participation or waiting for the program to begin.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Body Mass Index ≥25
- All types of stroke
- Able to Participate in Physical Activity
- ≥12 months post first stroke
- Have internet, phone, or computer access, or be willing to use one provided by the study team
You likely can't join if
- Contraindications for physical activity
- Low Cognitive Function
- Residing in hospital, acute rehab, skilled nursing facility
- Not fluent in the English language
- Pre-existing eating disorder
- Pregnancy
The study team makes the final eligibility decision.
Where it is enrolling
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Dallas, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.